Key result
OAC withdrawal guided by low AF burden on CIEDs resulted in fewer bleeding events compared to OAC continuation in high AF burden patients.
Why the study?
Does CIED-guided AF burden assessment allow safe withdrawal of long-term OAC in NVAF patients with high bleeding risk?
Cohort (n=145)
Does CIED-guided AF burden assessment allow safe withdrawal of long-term OAC in NVAF patients with high bleeding risk?
CIED-guided AF burden assessment may allow for the safe discontinuation of oral anticoagulation in high-bleeding-risk NVAF patients with low AF burden.
Answers are grounded in this paper and cite their sources.
CIED-guided OAC withdrawal may reduce bleeding in low-burden NVAF; leaves open safety and efficacy pending randomized trials.
BACKGROUND: Many patients with non-valvular atrial fibrillation (NVAF) with high risk for thromboembolic stroke and bleeding may not wish to continue long-term oral anticoagulants (OACs) to avoid bleeding complications. We aimed to investigate whether AF burden assessment by cardiovascular implantable electronic devices (CIEDs) would allow an individualised disease-guided approach for safe withdrawal of long-term OAC in high-risk patients. METHODS AND These patients wished to stay off long-term OAC based on their previous adverse bleeding event/s or due to similar events witnessed in the family or friend circle. These patients were grouped into 'low AF burden' [n = 121 (83%)], or 'high AF burden' [n = 24 (17%)] defined as <24 hours or >24 hours cumulatively in 30 consecutive days respectively, and followed for 51.2 ± 29.8 months. All patients with 'low AF burden' were allowed to discontinue OAC, but OAC was resumed in 1 patient who experienced TIA. Bleeding events developed in 9 out of 24 (37.5%) patients with 'high AF burden' who were maintained on OAC, as compared to 3 out of 121 (2.47%) patients with 'low AF burden' who were off OAC (p <.05). There were 9 (6.2%) deaths unrelated to AF treatment approach. CONCLUSIONS: In NVAF patients, AF burden assessment by CIEDs allows an individualised disease-guided approach to safe withdrawal of long-term OAC in patients with high bleeding risk who do not wish to continue long-term anticoagulation.
No takes yet. Share an insight, caveat, or question.
Mascarenhas et al. (2018) conducted a cohort in Non-valvular atrial fibrillation (n=145). Low AF burden (<24 hours in 30 days) with OAC withdrawal vs. High AF burden (>24 hours in 30 days) maintained on OAC was evaluated on Bleeding events (p=<.05). OAC withdrawal guided by low AF burden on CIEDs resulted in fewer bleeding events compared to OAC continuation in high AF burden patients.
Synapse has enriched 10 related papers. Consider them for comparative context: